GDF15 has emerged as a notable biomarker in metabolic dysfunction-associated fatty liver disease/metabolic dysfunction-associated steatohepatitis (MASLD/MASH) through cross-species investigations. This evidence concerns the gene GDF15 and metabolic dysfunction-associated steatohepatitis.